WealthPLAN Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,320
Closed -$210K 339
2023
Q3
$210K Buy
1,320
+1,300
+6,500% +$213K 0.02% 296
2023
Q2
$2.83K Buy
+20
New +$3.21K ﹤0.01% 1017

Other funds holding RGEN

WealthPLAN Partners's RGEN Position: Q4 2023 in Review

WealthPLAN Partners sold out of Repligen (RGEN) in Q4 2023, closing a stake of 1,320 shares — an estimated $210K sold.

WealthPLAN Partners first reported a position in RGEN in Q2 2023 and held it in 2 quarters. The position peaked at $210K in Q3 2023. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • WealthPLAN Partners reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 1,320 Repligen shares in Q4 2023, an estimated $210K.
  • WealthPLAN Partners first reported a position in Repligen in Q2 2023 and held it in 2 quarters.
  • WealthPLAN Partners's Repligen position peaked at $210K in Q3 2023.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on WealthPLAN Partners's 13F filing for Q4 2023, filed 5 Jan 2024.